Koninklijke Philips N.V.
Koninklijke Philips N.V. RYLPF Peers
See (RYLPF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| RYLPF | $24.83 | +1.20% | 22.97B | 82.76 | $0.30 | N/A |
| SMMNY | $27.05 | +2.31% | 121.35B | 27.05 | $1.00 | +0.99% |
| SEMHF | $53.97 | +4.38% | 60.52B | 26.98 | $2.00 | +2.04% |
| SONVY | $63.30 | +0.68% | 18.86B | 27.52 | $2.30 | +1.79% |
| SONVF | $315.98 | +2.89% | 18.83B | 27.50 | $11.49 | +1.80% |
| SNNUF | $14.33 | +1.13% | 12.54B | 30.49 | $0.47 | +2.62% |
| CHEOY | $85.56 | +2.26% | 11.19B | 46.75 | $1.83 | +1.64% |
| CHEOF | $169.96 | N/A | 11.09B | 46.56 | $3.65 | +1.63% |
| WILYY | $18.78 | +0.86% | 8.00B | 18.59 | $1.01 | N/A |
| WILLF | $36.25 | N/A | 7.46B | 17.95 | $2.02 | N/A |
Stock Comparison
RYLPF vs SMMNY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SMMNY has a market cap of 121.35B. Regarding current trading prices, RYLPF is priced at $24.83, while SMMNY trades at $27.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SMMNY's P/E ratio is 27.05. In terms of profitability, RYLPF's ROE is -0.06%, compared to SMMNY's ROE of +0.11%. Regarding short-term risk, RYLPF is more volatile compared to SMMNY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SEMHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SEMHF has a market cap of 60.52B. Regarding current trading prices, RYLPF is priced at $24.83, while SEMHF trades at $53.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SEMHF's P/E ratio is 26.98. In terms of profitability, RYLPF's ROE is -0.06%, compared to SEMHF's ROE of +0.11%. Regarding short-term risk, RYLPF is more volatile compared to SEMHF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SONVY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SONVY has a market cap of 18.86B. Regarding current trading prices, RYLPF is priced at $24.83, while SONVY trades at $63.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SONVY's P/E ratio is 27.52. In terms of profitability, RYLPF's ROE is -0.06%, compared to SONVY's ROE of +0.26%. Regarding short-term risk, RYLPF is more volatile compared to SONVY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SONVF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SONVF has a market cap of 18.83B. Regarding current trading prices, RYLPF is priced at $24.83, while SONVF trades at $315.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SONVF's P/E ratio is 27.50. In terms of profitability, RYLPF's ROE is -0.06%, compared to SONVF's ROE of +0.26%. Regarding short-term risk, RYLPF is less volatile compared to SONVF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SNNUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SNNUF has a market cap of 12.54B. Regarding current trading prices, RYLPF is priced at $24.83, while SNNUF trades at $14.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SNNUF's P/E ratio is 30.49. In terms of profitability, RYLPF's ROE is -0.06%, compared to SNNUF's ROE of +0.08%. Regarding short-term risk, RYLPF is more volatile compared to SNNUF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CHEOY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CHEOY has a market cap of 11.19B. Regarding current trading prices, RYLPF is priced at $24.83, while CHEOY trades at $85.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CHEOY's P/E ratio is 46.75. In terms of profitability, RYLPF's ROE is -0.06%, compared to CHEOY's ROE of +0.20%. Regarding short-term risk, RYLPF is more volatile compared to CHEOY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CHEOF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CHEOF has a market cap of 11.09B. Regarding current trading prices, RYLPF is priced at $24.83, while CHEOF trades at $169.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CHEOF's P/E ratio is 46.56. In terms of profitability, RYLPF's ROE is -0.06%, compared to CHEOF's ROE of +0.20%. Regarding short-term risk, RYLPF is less volatile compared to CHEOF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs WILYY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, WILYY has a market cap of 8.00B. Regarding current trading prices, RYLPF is priced at $24.83, while WILYY trades at $18.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas WILYY's P/E ratio is 18.59. In terms of profitability, RYLPF's ROE is -0.06%, compared to WILYY's ROE of +0.25%. Regarding short-term risk, RYLPF is more volatile compared to WILYY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs WILLF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, WILLF has a market cap of 7.46B. Regarding current trading prices, RYLPF is priced at $24.83, while WILLF trades at $36.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas WILLF's P/E ratio is 17.95. In terms of profitability, RYLPF's ROE is -0.06%, compared to WILLF's ROE of +0.25%. Regarding short-term risk, RYLPF is more volatile compared to WILLF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GNGBY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, GNGBY has a market cap of 5.44B. Regarding current trading prices, RYLPF is priced at $24.83, while GNGBY trades at $19.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas GNGBY's P/E ratio is 35.33. In terms of profitability, RYLPF's ROE is -0.06%, compared to GNGBY's ROE of +0.05%. Regarding short-term risk, RYLPF is more volatile compared to GNGBY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GNGBF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, GNGBF has a market cap of 5.37B. Regarding current trading prices, RYLPF is priced at $24.83, while GNGBF trades at $21.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas GNGBF's P/E ratio is 37.70. In terms of profitability, RYLPF's ROE is -0.06%, compared to GNGBF's ROE of +0.05%. Regarding short-term risk, RYLPF is less volatile compared to GNGBF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AMBFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, AMBFF has a market cap of 4.13B. Regarding current trading prices, RYLPF is priced at $24.83, while AMBFF trades at $17.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas AMBFF's P/E ratio is 84.76. In terms of profitability, RYLPF's ROE is -0.06%, compared to AMBFF's ROE of +0.06%. Regarding short-term risk, RYLPF is less volatile compared to AMBFF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AMBBY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, AMBBY has a market cap of 4.01B. Regarding current trading prices, RYLPF is priced at $24.83, while AMBBY trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas AMBBY's P/E ratio is 72.33. In terms of profitability, RYLPF's ROE is -0.06%, compared to AMBBY's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to AMBBY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NHNKY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, NHNKY has a market cap of 3.99B. Regarding current trading prices, RYLPF is priced at $24.83, while NHNKY trades at $12.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas NHNKY's P/E ratio is 16.83. In terms of profitability, RYLPF's ROE is -0.06%, compared to NHNKY's ROE of +0.06%. Regarding short-term risk, RYLPF is less volatile compared to NHNKY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NHNKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, NHNKF has a market cap of 2.48B. Regarding current trading prices, RYLPF is priced at $24.83, while NHNKF trades at $15.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas NHNKF's P/E ratio is 41.86. In terms of profitability, RYLPF's ROE is -0.06%, compared to NHNKF's ROE of +0.06%. Regarding short-term risk, RYLPF is more volatile compared to NHNKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VTRLY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, VTRLY has a market cap of 2.22B. Regarding current trading prices, RYLPF is priced at $24.83, while VTRLY trades at $16.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas VTRLY's P/E ratio is 43.13. In terms of profitability, RYLPF's ROE is -0.06%, compared to VTRLY's ROE of +0.04%. Regarding short-term risk, RYLPF is more volatile compared to VTRLY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GNNDY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, GNNDY has a market cap of 2.11B. Regarding current trading prices, RYLPF is priced at $24.83, while GNNDY trades at $43.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas GNNDY's P/E ratio is 17.33. In terms of profitability, RYLPF's ROE is -0.06%, compared to GNNDY's ROE of +0.08%. Regarding short-term risk, RYLPF is more volatile compared to GNNDY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs STSEY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, STSEY has a market cap of 2.04B. Regarding current trading prices, RYLPF is priced at $24.83, while STSEY trades at $6.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas STSEY's P/E ratio is 39.41. In terms of profitability, RYLPF's ROE is -0.06%, compared to STSEY's ROE of +0.04%. Regarding short-term risk, RYLPF is more volatile compared to STSEY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SSII Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SSII has a market cap of 1.96B. Regarding current trading prices, RYLPF is priced at $24.83, while SSII trades at $10.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SSII's P/E ratio is -92.27. In terms of profitability, RYLPF's ROE is -0.06%, compared to SSII's ROE of -1.33%. Regarding short-term risk, RYLPF is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GGNDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, GGNDF has a market cap of 1.89B. Regarding current trading prices, RYLPF is priced at $24.83, while GGNDF trades at $13.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas GGNDF's P/E ratio is 15.48. In terms of profitability, RYLPF's ROE is -0.06%, compared to GGNDF's ROE of +0.08%. Regarding short-term risk, RYLPF is less volatile compared to GGNDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs OSSFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, OSSFF has a market cap of 1.77B. Regarding current trading prices, RYLPF is priced at $24.83, while OSSFF trades at $4.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas OSSFF's P/E ratio is 24.41. In terms of profitability, RYLPF's ROE is -0.06%, compared to OSSFF's ROE of +0.09%. Regarding short-term risk, RYLPF is less volatile compared to OSSFF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DWRKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, DWRKF has a market cap of 1.75B. Regarding current trading prices, RYLPF is priced at $24.83, while DWRKF trades at $543.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas DWRKF's P/E ratio is 75.94. In terms of profitability, RYLPF's ROE is -0.06%, compared to DWRKF's ROE of N/A. Regarding short-term risk, RYLPF is more volatile compared to DWRKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MCRPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, MCRPF has a market cap of 1.73B. Regarding current trading prices, RYLPF is priced at $24.83, while MCRPF trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas MCRPF's P/E ratio is -7.77. In terms of profitability, RYLPF's ROE is -0.06%, compared to MCRPF's ROE of -0.33%. Regarding short-term risk, RYLPF is more volatile compared to MCRPF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs OSSUY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, OSSUY has a market cap of 1.71B. Regarding current trading prices, RYLPF is priced at $24.83, while OSSUY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas OSSUY's P/E ratio is 23.53. In terms of profitability, RYLPF's ROE is -0.06%, compared to OSSUY's ROE of +0.09%. Regarding short-term risk, RYLPF is more volatile compared to OSSUY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MEDGF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, MEDGF has a market cap of 1.67B. Regarding current trading prices, RYLPF is priced at $24.83, while MEDGF trades at $83.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas MEDGF's P/E ratio is 33.30. In terms of profitability, RYLPF's ROE is -0.06%, compared to MEDGF's ROE of +0.16%. Regarding short-term risk, RYLPF is more volatile compared to MEDGF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DRWKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, DRWKF has a market cap of 1.19B. Regarding current trading prices, RYLPF is priced at $24.83, while DRWKF trades at $67.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas DRWKF's P/E ratio is 9.01. In terms of profitability, RYLPF's ROE is -0.06%, compared to DRWKF's ROE of +0.09%. Regarding short-term risk, RYLPF is less volatile compared to DRWKF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs XVIPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, XVIPF has a market cap of 1.04B. Regarding current trading prices, RYLPF is priced at $24.83, while XVIPF trades at $32.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas XVIPF's P/E ratio is 73.11. In terms of profitability, RYLPF's ROE is -0.06%, compared to XVIPF's ROE of +0.07%. Regarding short-term risk, RYLPF is more volatile compared to XVIPF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LFTSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, LFTSF has a market cap of 1.03B. Regarding current trading prices, RYLPF is priced at $24.83, while LFTSF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas LFTSF's P/E ratio is 23.35. In terms of profitability, RYLPF's ROE is -0.06%, compared to LFTSF's ROE of +0.07%. Regarding short-term risk, RYLPF is more volatile compared to LFTSF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DGWPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, DGWPF has a market cap of 928.48M. Regarding current trading prices, RYLPF is priced at $24.83, while DGWPF trades at $45.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas DGWPF's P/E ratio is 6.88. In terms of profitability, RYLPF's ROE is -0.06%, compared to DGWPF's ROE of +0.09%. Regarding short-term risk, RYLPF is less volatile compared to DGWPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ELEAF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, ELEAF has a market cap of 832.49M. Regarding current trading prices, RYLPF is priced at $24.83, while ELEAF trades at $10.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas ELEAF's P/E ratio is 12.08. In terms of profitability, RYLPF's ROE is -0.06%, compared to ELEAF's ROE of +0.14%. Regarding short-term risk, RYLPF is less volatile compared to ELEAF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MDRSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, MDRSF has a market cap of 826.63M. Regarding current trading prices, RYLPF is priced at $24.83, while MDRSF trades at $66.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas MDRSF's P/E ratio is 196.12. In terms of profitability, RYLPF's ROE is -0.06%, compared to MDRSF's ROE of +0.01%. Regarding short-term risk, RYLPF is less volatile compared to MDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CALZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CALZF has a market cap of 650.77M. Regarding current trading prices, RYLPF is priced at $24.83, while CALZF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CALZF's P/E ratio is 94.20. In terms of profitability, RYLPF's ROE is -0.06%, compared to CALZF's ROE of +0.07%. Regarding short-term risk, RYLPF is less volatile compared to CALZF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AVMR Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, AVMR has a market cap of 494.15M. Regarding current trading prices, RYLPF is priced at $24.83, while AVMR trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas AVMR's P/E ratio is -18.34. In terms of profitability, RYLPF's ROE is -0.06%, compared to AVMR's ROE of -0.24%. Regarding short-term risk, RYLPF is more volatile compared to AVMR. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CLVSF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CLVSF has a market cap of 459.85M. Regarding current trading prices, RYLPF is priced at $24.83, while CLVSF trades at $19.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CLVSF's P/E ratio is 31.61. In terms of profitability, RYLPF's ROE is -0.06%, compared to CLVSF's ROE of +0.18%. Regarding short-term risk, RYLPF is less volatile compared to CLVSF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs HYBT Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, HYBT has a market cap of 361.36M. Regarding current trading prices, RYLPF is priced at $24.83, while HYBT trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas HYBT's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is -0.06%, compared to HYBT's ROE of -0.02%. Regarding short-term risk, RYLPF is more volatile compared to HYBT. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IOBCF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, IOBCF has a market cap of 326.64M. Regarding current trading prices, RYLPF is priced at $24.83, while IOBCF trades at $11.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas IOBCF's P/E ratio is 35.97. In terms of profitability, RYLPF's ROE is -0.06%, compared to IOBCF's ROE of +0.08%. Regarding short-term risk, RYLPF is more volatile compared to IOBCF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs EAPIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, EAPIF has a market cap of 290.45M. Regarding current trading prices, RYLPF is priced at $24.83, while EAPIF trades at $3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas EAPIF's P/E ratio is -1.96. In terms of profitability, RYLPF's ROE is -0.06%, compared to EAPIF's ROE of -0.31%. Regarding short-term risk, RYLPF is less volatile compared to EAPIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CSSPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CSSPF has a market cap of 263.38M. Regarding current trading prices, RYLPF is priced at $24.83, while CSSPF trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CSSPF's P/E ratio is 65.00. In terms of profitability, RYLPF's ROE is -0.06%, compared to CSSPF's ROE of +0.16%. Regarding short-term risk, RYLPF is less volatile compared to CSSPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CYBQY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CYBQY has a market cap of 261.21M. Regarding current trading prices, RYLPF is priced at $24.83, while CYBQY trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CYBQY's P/E ratio is -40.67. In terms of profitability, RYLPF's ROE is -0.06%, compared to CYBQY's ROE of -0.02%. Regarding short-term risk, RYLPF is less volatile compared to CYBQY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SNWV Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SNWV has a market cap of 261.16M. Regarding current trading prices, RYLPF is priced at $24.83, while SNWV trades at $30.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SNWV's P/E ratio is -4.35. In terms of profitability, RYLPF's ROE is -0.06%, compared to SNWV's ROE of +0.78%. Regarding short-term risk, RYLPF is less volatile compared to SNWV. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CLLKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CLLKF has a market cap of 252.12M. Regarding current trading prices, RYLPF is priced at $24.83, while CLLKF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CLLKF's P/E ratio is -8.11. In terms of profitability, RYLPF's ROE is -0.06%, compared to CLLKF's ROE of -0.12%. Regarding short-term risk, RYLPF is more volatile compared to CLLKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BCCOY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, BCCOY has a market cap of 249.26M. Regarding current trading prices, RYLPF is priced at $24.83, while BCCOY trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas BCCOY's P/E ratio is -8.18. In terms of profitability, RYLPF's ROE is -0.06%, compared to BCCOY's ROE of -0.12%. Regarding short-term risk, RYLPF is less volatile compared to BCCOY. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AVHHL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, AVHHL has a market cap of 246.64M. Regarding current trading prices, RYLPF is priced at $24.83, while AVHHL trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas AVHHL's P/E ratio is -4.75. In terms of profitability, RYLPF's ROE is -0.06%, compared to AVHHL's ROE of -3.38%. Regarding short-term risk, RYLPF is more volatile compared to AVHHL. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs HTLZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, HTLZF has a market cap of 245.15M. Regarding current trading prices, RYLPF is priced at $24.83, while HTLZF trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas HTLZF's P/E ratio is -159.01. In terms of profitability, RYLPF's ROE is -0.06%, compared to HTLZF's ROE of -0.03%. Regarding short-term risk, RYLPF is more volatile compared to HTLZF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IMPZY Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, IMPZY has a market cap of 199.95M. Regarding current trading prices, RYLPF is priced at $24.83, while IMPZY trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas IMPZY's P/E ratio is -1.60. In terms of profitability, RYLPF's ROE is -0.06%, compared to IMPZY's ROE of -3.64%. Regarding short-term risk, RYLPF is more volatile compared to IMPZY. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CYBQF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CYBQF has a market cap of 173.46M. Regarding current trading prices, RYLPF is priced at $24.83, while CYBQF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CYBQF's P/E ratio is -43.33. In terms of profitability, RYLPF's ROE is -0.06%, compared to CYBQF's ROE of -0.02%. Regarding short-term risk, RYLPF is more volatile compared to CYBQF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs EKDHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, EKDHF has a market cap of 162.48M. Regarding current trading prices, RYLPF is priced at $24.83, while EKDHF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas EKDHF's P/E ratio is 18.00. In terms of profitability, RYLPF's ROE is -0.06%, compared to EKDHF's ROE of +0.09%. Regarding short-term risk, RYLPF is less volatile compared to EKDHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BRNHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, BRNHF has a market cap of 161.85M. Regarding current trading prices, RYLPF is priced at $24.83, while BRNHF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas BRNHF's P/E ratio is -5.12. In terms of profitability, RYLPF's ROE is -0.06%, compared to BRNHF's ROE of -0.09%. Regarding short-term risk, RYLPF is less volatile compared to BRNHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs JMDMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, JMDMF has a market cap of 154.98M. Regarding current trading prices, RYLPF is priced at $24.83, while JMDMF trades at $5.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas JMDMF's P/E ratio is -43.25. In terms of profitability, RYLPF's ROE is -0.06%, compared to JMDMF's ROE of N/A. Regarding short-term risk, RYLPF is less volatile compared to JMDMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PXMBF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, PXMBF has a market cap of 151.86M. Regarding current trading prices, RYLPF is priced at $24.83, while PXMBF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas PXMBF's P/E ratio is 29.17. In terms of profitability, RYLPF's ROE is -0.06%, compared to PXMBF's ROE of +0.27%. Regarding short-term risk, RYLPF is more volatile compared to PXMBF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BRSYF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, BRSYF has a market cap of 128.39M. Regarding current trading prices, RYLPF is priced at $24.83, while BRSYF trades at $3.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas BRSYF's P/E ratio is 37.78. In terms of profitability, RYLPF's ROE is -0.06%, compared to BRSYF's ROE of +0.06%. Regarding short-term risk, RYLPF is less volatile compared to BRSYF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs AMEUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, AMEUF has a market cap of 120.50M. Regarding current trading prices, RYLPF is priced at $24.83, while AMEUF trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas AMEUF's P/E ratio is -1.75. In terms of profitability, RYLPF's ROE is -0.06%, compared to AMEUF's ROE of -6.21%. Regarding short-term risk, RYLPF is less volatile compared to AMEUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VMTHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, VMTHF has a market cap of 110.00M. Regarding current trading prices, RYLPF is priced at $24.83, while VMTHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas VMTHF's P/E ratio is -1.14. In terms of profitability, RYLPF's ROE is -0.06%, compared to VMTHF's ROE of -0.23%. Regarding short-term risk, RYLPF is less volatile compared to VMTHF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs FDMDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, FDMDF has a market cap of 102.68M. Regarding current trading prices, RYLPF is priced at $24.83, while FDMDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas FDMDF's P/E ratio is -3.26. In terms of profitability, RYLPF's ROE is -0.06%, compared to FDMDF's ROE of -0.44%. Regarding short-term risk, RYLPF is more volatile compared to FDMDF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RSHUF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, RSHUF has a market cap of 91.52M. Regarding current trading prices, RYLPF is priced at $24.83, while RSHUF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas RSHUF's P/E ratio is -5.81. In terms of profitability, RYLPF's ROE is -0.06%, compared to RSHUF's ROE of -2.32%. Regarding short-term risk, RYLPF is less volatile compared to RSHUF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs CKMTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, CKMTF has a market cap of 85.19M. Regarding current trading prices, RYLPF is priced at $24.83, while CKMTF trades at $12.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas CKMTF's P/E ratio is -3.32. In terms of profitability, RYLPF's ROE is -0.06%, compared to CKMTF's ROE of +2.13%. Regarding short-term risk, RYLPF is more volatile compared to CKMTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SOMNF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SOMNF has a market cap of 84.28M. Regarding current trading prices, RYLPF is priced at $24.83, while SOMNF trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SOMNF's P/E ratio is -13.00. In terms of profitability, RYLPF's ROE is -0.06%, compared to SOMNF's ROE of -0.38%. Regarding short-term risk, RYLPF is less volatile compared to SOMNF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DMTRF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, DMTRF has a market cap of 76.10M. Regarding current trading prices, RYLPF is priced at $24.83, while DMTRF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas DMTRF's P/E ratio is -9.86. In terms of profitability, RYLPF's ROE is -0.06%, compared to DMTRF's ROE of -0.24%. Regarding short-term risk, RYLPF is less volatile compared to DMTRF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IPDQF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, IPDQF has a market cap of 75.83M. Regarding current trading prices, RYLPF is priced at $24.83, while IPDQF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas IPDQF's P/E ratio is -3.74. In terms of profitability, RYLPF's ROE is -0.06%, compared to IPDQF's ROE of -0.43%. Regarding short-term risk, RYLPF is less volatile compared to IPDQF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs SNZZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, SNZZF has a market cap of 71.91M. Regarding current trading prices, RYLPF is priced at $24.83, while SNZZF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas SNZZF's P/E ratio is -5.40. In terms of profitability, RYLPF's ROE is -0.06%, compared to SNZZF's ROE of -0.40%. Regarding short-term risk, RYLPF is more volatile compared to SNZZF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RDGL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, RDGL has a market cap of 58.98M. Regarding current trading prices, RYLPF is priced at $24.83, while RDGL trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas RDGL's P/E ratio is -13.01. In terms of profitability, RYLPF's ROE is -0.06%, compared to RDGL's ROE of -1.86%. Regarding short-term risk, RYLPF is less volatile compared to RDGL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BLOZF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, BLOZF has a market cap of 48.38M. Regarding current trading prices, RYLPF is priced at $24.83, while BLOZF trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas BLOZF's P/E ratio is -21.01. In terms of profitability, RYLPF's ROE is -0.06%, compared to BLOZF's ROE of -0.89%. Regarding short-term risk, RYLPF is less volatile compared to BLOZF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NVYTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, NVYTF has a market cap of 38.00M. Regarding current trading prices, RYLPF is priced at $24.83, while NVYTF trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas NVYTF's P/E ratio is -0.78. In terms of profitability, RYLPF's ROE is -0.06%, compared to NVYTF's ROE of -0.23%. Regarding short-term risk, RYLPF is less volatile compared to NVYTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TLTFF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, TLTFF has a market cap of 34.24M. Regarding current trading prices, RYLPF is priced at $24.83, while TLTFF trades at $0.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas TLTFF's P/E ratio is -13.82. In terms of profitability, RYLPF's ROE is -0.06%, compared to TLTFF's ROE of -2.17%. Regarding short-term risk, RYLPF is more volatile compared to TLTFF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ELXMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, ELXMF has a market cap of 28.41M. Regarding current trading prices, RYLPF is priced at $24.83, while ELXMF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas ELXMF's P/E ratio is -2.00. In terms of profitability, RYLPF's ROE is -0.06%, compared to ELXMF's ROE of -0.46%. Regarding short-term risk, RYLPF is more volatile compared to ELXMF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PYNKF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, PYNKF has a market cap of 24.77M. Regarding current trading prices, RYLPF is priced at $24.83, while PYNKF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas PYNKF's P/E ratio is -1.47. In terms of profitability, RYLPF's ROE is -0.06%, compared to PYNKF's ROE of -1.17%. Regarding short-term risk, RYLPF is more volatile compared to PYNKF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs KBBTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, KBBTF has a market cap of 24.10M. Regarding current trading prices, RYLPF is priced at $24.83, while KBBTF trades at $0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas KBBTF's P/E ratio is -2.30. In terms of profitability, RYLPF's ROE is -0.06%, compared to KBBTF's ROE of N/A. Regarding short-term risk, RYLPF is more volatile compared to KBBTF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs EMITF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, EMITF has a market cap of 22.19M. Regarding current trading prices, RYLPF is priced at $24.83, while EMITF trades at $2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas EMITF's P/E ratio is -14.29. In terms of profitability, RYLPF's ROE is -0.06%, compared to EMITF's ROE of +0.05%. Regarding short-term risk, RYLPF is less volatile compared to EMITF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs POSC Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, POSC has a market cap of 19.42M. Regarding current trading prices, RYLPF is priced at $24.83, while POSC trades at $1.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas POSC's P/E ratio is 0.32. In terms of profitability, RYLPF's ROE is -0.06%, compared to POSC's ROE of +9.25%. Regarding short-term risk, RYLPF is more volatile compared to POSC. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ASAPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, ASAPF has a market cap of 16.93M. Regarding current trading prices, RYLPF is priced at $24.83, while ASAPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas ASAPF's P/E ratio is -21.92. In terms of profitability, RYLPF's ROE is -0.06%, compared to ASAPF's ROE of -0.20%. Regarding short-term risk, RYLPF is less volatile compared to ASAPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VPTDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, VPTDF has a market cap of 16.18M. Regarding current trading prices, RYLPF is priced at $24.83, while VPTDF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas VPTDF's P/E ratio is -4.96. In terms of profitability, RYLPF's ROE is -0.06%, compared to VPTDF's ROE of +3.89%. Regarding short-term risk, RYLPF is less volatile compared to VPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MDXHF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, MDXHF has a market cap of 15.49M. Regarding current trading prices, RYLPF is priced at $24.83, while MDXHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas MDXHF's P/E ratio is -0.08. In terms of profitability, RYLPF's ROE is -0.06%, compared to MDXHF's ROE of +0.39%. Regarding short-term risk, RYLPF is more volatile compared to MDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TMDIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, TMDIF has a market cap of 13.91M. Regarding current trading prices, RYLPF is priced at $24.83, while TMDIF trades at $0.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas TMDIF's P/E ratio is -0.65. In terms of profitability, RYLPF's ROE is -0.06%, compared to TMDIF's ROE of -1.06%. Regarding short-term risk, RYLPF is less volatile compared to TMDIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DIZTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, DIZTF has a market cap of 13.69M. Regarding current trading prices, RYLPF is priced at $24.83, while DIZTF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas DIZTF's P/E ratio is -5.67. In terms of profitability, RYLPF's ROE is -0.06%, compared to DIZTF's ROE of -2.82%. Regarding short-term risk, RYLPF is less volatile compared to DIZTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PLLWF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, PLLWF has a market cap of 13.28M. Regarding current trading prices, RYLPF is priced at $24.83, while PLLWF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas PLLWF's P/E ratio is -0.37. In terms of profitability, RYLPF's ROE is -0.06%, compared to PLLWF's ROE of -0.65%. Regarding short-term risk, RYLPF is less volatile compared to PLLWF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RMSL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, RMSL has a market cap of 12.90M. Regarding current trading prices, RYLPF is priced at $24.83, while RMSL trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas RMSL's P/E ratio is 0.84. In terms of profitability, RYLPF's ROE is -0.06%, compared to RMSL's ROE of -1.94%. Regarding short-term risk, RYLPF is less volatile compared to RMSL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IMEXF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, IMEXF has a market cap of 11.66M. Regarding current trading prices, RYLPF is priced at $24.83, while IMEXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas IMEXF's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is -0.06%, compared to IMEXF's ROE of +0.20%. Regarding short-term risk, RYLPF is less volatile compared to IMEXF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NGMDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, NGMDF has a market cap of 11.51M. Regarding current trading prices, RYLPF is priced at $24.83, while NGMDF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas NGMDF's P/E ratio is -1.83. In terms of profitability, RYLPF's ROE is -0.06%, compared to NGMDF's ROE of +2.16%. Regarding short-term risk, RYLPF is less volatile compared to NGMDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ATBPF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, ATBPF has a market cap of 11.43M. Regarding current trading prices, RYLPF is priced at $24.83, while ATBPF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas ATBPF's P/E ratio is -0.86. In terms of profitability, RYLPF's ROE is -0.06%, compared to ATBPF's ROE of -0.40%. Regarding short-term risk, RYLPF is less volatile compared to ATBPF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LXXGF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, LXXGF has a market cap of 11.34M. Regarding current trading prices, RYLPF is priced at $24.83, while LXXGF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas LXXGF's P/E ratio is -0.85. In terms of profitability, RYLPF's ROE is -0.06%, compared to LXXGF's ROE of -1.23%. Regarding short-term risk, RYLPF is more volatile compared to LXXGF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs GTHP Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, GTHP has a market cap of 8.19M. Regarding current trading prices, RYLPF is priced at $24.83, while GTHP trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas GTHP's P/E ratio is -2.10. In terms of profitability, RYLPF's ROE is -0.06%, compared to GTHP's ROE of +0.56%. Regarding short-term risk, RYLPF is less volatile compared to GTHP. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VYCO Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, VYCO has a market cap of 6.64M. Regarding current trading prices, RYLPF is priced at $24.83, while VYCO trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas VYCO's P/E ratio is -19.90. In terms of profitability, RYLPF's ROE is -0.06%, compared to VYCO's ROE of +0.03%. Regarding short-term risk, RYLPF is more volatile compared to VYCO. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MKEAF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, MKEAF has a market cap of 6.60M. Regarding current trading prices, RYLPF is priced at $24.83, while MKEAF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas MKEAF's P/E ratio is -4.11. In terms of profitability, RYLPF's ROE is -0.06%, compared to MKEAF's ROE of +0.60%. Regarding short-term risk, RYLPF is more volatile compared to MKEAF. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs IRME Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, IRME has a market cap of 5.88M. Regarding current trading prices, RYLPF is priced at $24.83, while IRME trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas IRME's P/E ratio is -2.72. In terms of profitability, RYLPF's ROE is -0.06%, compared to IRME's ROE of +506.40%. Regarding short-term risk, RYLPF is less volatile compared to IRME. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs DTXMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, DTXMF has a market cap of 5.69M. Regarding current trading prices, RYLPF is priced at $24.83, while DTXMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas DTXMF's P/E ratio is -0.30. In terms of profitability, RYLPF's ROE is -0.06%, compared to DTXMF's ROE of -0.41%. Regarding short-term risk, RYLPF is less volatile compared to DTXMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs TBRIF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, TBRIF has a market cap of 5.59M. Regarding current trading prices, RYLPF is priced at $24.83, while TBRIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas TBRIF's P/E ratio is -1.23. In terms of profitability, RYLPF's ROE is -0.06%, compared to TBRIF's ROE of -2.22%. Regarding short-term risk, RYLPF is less volatile compared to TBRIF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs QLIS Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, QLIS has a market cap of 5.45M. Regarding current trading prices, RYLPF is priced at $24.83, while QLIS trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas QLIS's P/E ratio is 2.22. In terms of profitability, RYLPF's ROE is -0.06%, compared to QLIS's ROE of -8.21%. Regarding short-term risk, RYLPF is more volatile compared to QLIS. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs RHNMF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, RHNMF has a market cap of 5.45M. Regarding current trading prices, RYLPF is priced at $24.83, while RHNMF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas RHNMF's P/E ratio is -0.95. In terms of profitability, RYLPF's ROE is -0.06%, compared to RHNMF's ROE of -2.48%. Regarding short-term risk, RYLPF is less volatile compared to RHNMF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ADMT Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, ADMT has a market cap of 4.73M. Regarding current trading prices, RYLPF is priced at $24.83, while ADMT trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas ADMT's P/E ratio is -7.00. In terms of profitability, RYLPF's ROE is -0.06%, compared to ADMT's ROE of -0.63%. Regarding short-term risk, RYLPF is more volatile compared to ADMT. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs MICR Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, MICR has a market cap of 4.73M. Regarding current trading prices, RYLPF is priced at $24.83, while MICR trades at $1.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas MICR's P/E ratio is -3.47. In terms of profitability, RYLPF's ROE is -0.06%, compared to MICR's ROE of -0.25%. Regarding short-term risk, RYLPF is less volatile compared to MICR. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs FZMD Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, FZMD has a market cap of 4.51M. Regarding current trading prices, RYLPF is priced at $24.83, while FZMD trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas FZMD's P/E ratio is 1.22. In terms of profitability, RYLPF's ROE is -0.06%, compared to FZMD's ROE of +0.13%. Regarding short-term risk, RYLPF is more volatile compared to FZMD. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs NUMD Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, NUMD has a market cap of 4.18M. Regarding current trading prices, RYLPF is priced at $24.83, while NUMD trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas NUMD's P/E ratio is 5.00. In terms of profitability, RYLPF's ROE is -0.06%, compared to NUMD's ROE of +0.35%. Regarding short-term risk, RYLPF is less volatile compared to NUMD. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LBLTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, LBLTF has a market cap of 4.07M. Regarding current trading prices, RYLPF is priced at $24.83, while LBLTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas LBLTF's P/E ratio is -0.01. In terms of profitability, RYLPF's ROE is -0.06%, compared to LBLTF's ROE of +0.00%. Regarding short-term risk, RYLPF is less volatile compared to LBLTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs BIEL Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, BIEL has a market cap of 3.62M. Regarding current trading prices, RYLPF is priced at $24.83, while BIEL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas BIEL's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is -0.06%, compared to BIEL's ROE of +0.04%. Regarding short-term risk, RYLPF is less volatile compared to BIEL. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs VANIW Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, VANIW has a market cap of 3.36M. Regarding current trading prices, RYLPF is priced at $24.83, while VANIW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas VANIW's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is -0.06%, compared to VANIW's ROE of -1.06%. Regarding short-term risk, RYLPF is less volatile compared to VANIW. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs PMEDF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, PMEDF has a market cap of 2.25M. Regarding current trading prices, RYLPF is priced at $24.83, while PMEDF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas PMEDF's P/E ratio is -1.50. In terms of profitability, RYLPF's ROE is -0.06%, compared to PMEDF's ROE of +1.68%. Regarding short-term risk, RYLPF is less volatile compared to PMEDF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs ALRTF Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, ALRTF has a market cap of 2.22M. Regarding current trading prices, RYLPF is priced at $24.83, while ALRTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas ALRTF's P/E ratio is -0.12. In terms of profitability, RYLPF's ROE is -0.06%, compared to ALRTF's ROE of +0.52%. Regarding short-term risk, RYLPF is less volatile compared to ALRTF. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs LLBO Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, LLBO has a market cap of 2.17M. Regarding current trading prices, RYLPF is priced at $24.83, while LLBO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas LLBO's P/E ratio is N/A. In terms of profitability, RYLPF's ROE is -0.06%, compared to LLBO's ROE of +0.00%. Regarding short-term risk, RYLPF is more volatile compared to LLBO. This indicates potentially higher risk in terms of short-term price fluctuations for RYLPF.
RYLPF vs USAQ Comparison
RYLPF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, RYLPF stands at 22.97B. In comparison, USAQ has a market cap of 1.83M. Regarding current trading prices, RYLPF is priced at $24.83, while USAQ trades at $0.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
RYLPF currently has a P/E ratio of 82.76, whereas USAQ's P/E ratio is -5.41. In terms of profitability, RYLPF's ROE is -0.06%, compared to USAQ's ROE of +0.61%. Regarding short-term risk, RYLPF is less volatile compared to USAQ. This indicates potentially lower risk in terms of short-term price fluctuations for RYLPF.